Europe — EMA

Novomix 30 Penfill (Insulin Aspart)

Request sourcing

Pack/s

What is Insulin Aspart?

Insulin aspart, the active ingredient in Novomix 30 Penfill, is an insulin analog presented as a pre‑filled pen for subcutaneous use. It controls blood glucose levels in people with diabetes mellitus. GNH USA supplies Novomix 30 Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Novomix 30 Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Insulin Aspart used for?

Novomix 30 Penfill is an insulin analog that acts on the glucose regulation pathway in diabetes mellitus. - Type 1 diabetes mellitus: Improves basal and prandial glucose control. - Type 2 diabetes mellitus: Provides mealtime and basal insulin coverage. - Gestational diabetes mellitus: Assists with post‑prandial glucose management. - Diabetes‑related hyperglycaemia acute ...

What are the side effects of Insulin Aspart?

The … .... … … ...

What precautions apply to Insulin Aspart?

...

What does Insulin Aspart interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →